OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine

2011152 citationsJournal Article

Authors

This study provides Class 1A evidence that onabotulinumtoxinA treatment reduces headache impact and improves HRQoL.

Published in: Neurology

Volume 77, Issue 15, pp. 1465-1472

Field-Weighted Citation Impact: 7.08